Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0DN0W
|
||||
Drug Name |
Niraparib Tosylate
|
||||
Synonyms |
Zejula
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Recurrent epithelial ovarian or primary peritoneal cancer [ICD10:C78] | Approved | [889446] | ||
Company |
Tesaro
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Poly [ADP-ribose] polymerase-1 | Target Info | Modulator | [556264] | |
KEGG Pathway | Base excision repair | ||||
NF-kappa B signaling pathway | |||||
PANTHER Pathway | FAS signaling pathway | ||||
Pathway Interaction Database | Integrin-linked kinase signaling | ||||
Caspase Cascade in Apoptosis | |||||
Notch-mediated HES/HEY network | |||||
Reactome | Dual Incision in GG-NER | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.